Nuvalent Inc vs Charles Schwab Corporation Common Stock — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Charles Schwab Corporation Common Stock trades at $100.17 (market cap $178.33B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 18.2× Nuvalent Inc's market cap, and Charles Schwab Corporation Common Stock pays a 1.25% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SCHW | |
|---|---|---|
Market Cap | $9.81B | $178.33B |
Sector | Technology | Financials |
52-Week High | $123.96 | $107.21 |
52-Week Low | $72.16 | $85.35 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 1.25% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →